Palliative in-patient cancer treatment in an anthroposophic hospital: I. Treatment patterns and compliance with anthroposophic medicine

Forschende Komplementärmedizin = Research in Complementary Medicine
Peter HeusserThomas Cerny

Abstract

Complementary and alternative medicine (CAM) and most of all anthroposophic medicine (AM) are important features of cancer treatment in Switzerland. While the number of epidemiological investigations into the use of such therapies is increasing, there is a distinct lack of reports regarding the combination of conventional and CAM methods. 144 in-patients with advanced epithelial cancers were enrolled in a prospective quality-of-life (QoL) study at the Lukas Klinik (LK), Arlesheim, Switzerland. Tumor-related treatment was assessed 4 months prior to admission, during hospitalization and 4 months after baseline. We aimed at giving a detailed account of conventional, AM and CAM treatment patterns in palliative care, before, during and after hospitalization, with emphasis on compliance with AM after discharge. Certain conventional treatments featured less during hospitalization than before but were resumed after discharge (chemotherapy, radiotherapy, sleeping pills, psychoactive drugs). Hormone therapy, corticosteroids, analgesics WHO III and antidepressants remained constant. AM treatment consisted of Iscador? (mistletoe), other plant- or mineral-derived medication, baths, massage, eurythmy, art therapy, counseling and lactovegetar...Continue Reading

References

Jan 1, 1991·European Journal of Cancer : Official Journal for European Organization for Research and Treatment of Cancer (EORTC) [and] European Association for Cancer Research (EACR)·E KovacsK Hostanska
Jan 1, 1994·European Journal of Cancer : Official Journal for European Organization for Research and Treatment of Cancer (EORTC) [and] European Association for Cancer Research (EACR)·A BüssingK Schweizer
Jul 1, 1993·Current Opinion in Oncology·S P Hauser
Jan 28, 1993·The New England Journal of Medicine·E W Campion
Feb 1, 1997·Japanese Journal of Clinical Oncology·J M LiuJ Whang-Peng
Jan 24, 1998·Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology·J R Durant
May 30, 1998·JAMA : the Journal of the American Medical Association·J A Astin
Dec 22, 1998·Der Internist·G KaiserW M Gallmeier
Dec 29, 1998·Annals of Internal Medicine·T J Kaptchuk, D M Eisenberg
Jul 13, 2000·Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology·M A RichardsonS E Singletary
Jul 13, 2000·Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology·H BoonT Haines-Kamka
May 2, 2001·Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology·O PaltielV Soskolne
Dec 10, 2002·The Journal of Alternative and Complementary Medicine : Research on Paradigm, Practice, and Policy·Dianne M ShumayHisako Kakai
Jul 20, 2010·Journal of Advanced Nursing·Wolf LangewitzPaul Grossman
Dec 1, 1994·Phytomedicine : International Journal of Phytotherapy and Phytopharmacology·J Kleijnen, P Knipschild

❮ Previous
Next ❯

Citations

Oct 29, 2008·Evidence-based Complementary and Alternative Medicine : ECAM·Renatus Ziegler
Jun 28, 2011·Forschende Komplementärmedizin = Research in Complementary Medicine·Kristina GeueElmar Brähler
Apr 2, 2008·BMC Complementary and Alternative Medicine·Arndt BüssingPeter F Matthiessen
Jun 10, 2011·Chinese Medicine·Bridget Carmady, Caroline A Smith
Jan 15, 2014·Global Advances in Health and Medicine : Improving Healthcare Outcomes Worldwide·Gunver S KienleHelmut Kiene
Jan 9, 2015·Global Advances in Health and Medicine : Improving Healthcare Outcomes Worldwide·Gregory A Plotnikoff
Oct 2, 2008·Health and Quality of Life Outcomes·Barbara M EschPeter Heusser
May 31, 2016·Evidence-based Complementary and Alternative Medicine : ECAM·Gunver S KienleHelmut Kiene
Nov 23, 2011·Forschende Komplementärmedizin = Research in Complementary Medicine·Gunver Sophia KienleHelmut Kiene
Jul 27, 2006·Forschende Komplementärmedizin = Research in Complementary Medicine·Peter HeusserThomas Cerny

❮ Previous
Next ❯

Related Concepts

Trending Feeds

COVID-19

Coronaviruses encompass a large family of viruses that cause the common cold as well as more serious diseases, such as the ongoing outbreak of coronavirus disease 2019 (COVID-19; formally known as 2019-nCoV). Coronaviruses can spread from animals to humans; symptoms include fever, cough, shortness of breath, and breathing difficulties; in more severe cases, infection can lead to death. This feed covers recent research on COVID-19.

Blastomycosis

Blastomycosis fungal infections spread through inhaling Blastomyces dermatitidis spores. Discover the latest research on blastomycosis fungal infections here.

Nuclear Pore Complex in ALS/FTD

Alterations in nucleocytoplasmic transport, controlled by the nuclear pore complex, may be involved in the pathomechanism underlying multiple neurodegenerative diseases including Amyotrophic Lateral Sclerosis and Frontotemporal Dementia. Here is the latest research on the nuclear pore complex in ALS and FTD.

Applications of Molecular Barcoding

The concept of molecular barcoding is that each original DNA or RNA molecule is attached to a unique sequence barcode. Sequence reads having different barcodes represent different original molecules, while sequence reads having the same barcode are results of PCR duplication from one original molecule. Discover the latest research on molecular barcoding here.

Chronic Fatigue Syndrome

Chronic fatigue syndrome is a disease characterized by unexplained disabling fatigue; the pathology of which is incompletely understood. Discover the latest research on chronic fatigue syndrome here.

Evolution of Pluripotency

Pluripotency refers to the ability of a cell to develop into three primary germ cell layers of the embryo. This feed focuses on the mechanisms that underlie the evolution of pluripotency. Here is the latest research.

Position Effect Variegation

Position Effect Variagation occurs when a gene is inactivated due to its positioning near heterochromatic regions within a chromosome. Discover the latest research on Position Effect Variagation here.

STING Receptor Agonists

Stimulator of IFN genes (STING) are a group of transmembrane proteins that are involved in the induction of type I interferon that is important in the innate immune response. The stimulation of STING has been an active area of research in the treatment of cancer and infectious diseases. Here is the latest research on STING receptor agonists.

Microbicide

Microbicides are products that can be applied to vaginal or rectal mucosal surfaces with the goal of preventing, or at least significantly reducing, the transmission of sexually transmitted infections. Here is the latest research on microbicides.

Related Papers

Forschende Komplementärmedizin = Research in Complementary Medicine
Florica MarianAndré Busato
Forschende Komplementärmedizin = Research in Complementary Medicine
Roland Unkelbach, Heinz Harald Abholz
© 2022 Meta ULC. All rights reserved